All Stories

  1. The DNMT3B Inhibitor Nanaomycin A as a Neuroblastoma Therapeutic Agent

    Article • Current Cancer Drug Targets, December 2023, Bentham Science Publishers

    Yasumichi Inoue, Mineyoshi Aoyama

  2. The CDK inhibitor p21 is a novel target gene of ATF4 and contributes to cell survival under ER stress

    Article • FEBS Letters, October 2017, Wiley

    Yasumichi Inoue